Bone metastases are a very common problem in prostate cancer.
They are associated with considerable morbidity, adversely affect quality of life and frequently lead to advanced bone events (so-called skeletal-related events, SREs); SREs include fractures, spinal cord compression and the requirement for bone surgery or bone radiation. The aim of this paper was to evaluate currently available treatment options in the prevention and management of SREs and bone metastases in men with castration-resistant prostate cancer and to outline the importance of interdisciplinary management strategies. It also discusses the diagnostic workup of osseous metastases and practical considerations for the utilization of bone-targeted therapies in accordance with current guidelines to provide a consensus for special and/or difficult clinical situations.
Written by:
Cathomas R, Bajory Z, Bouzid M, El Ghoneimy A, Gillessen S, Goncalves F, Kacso G, Kramer G, Milecki P, Pacik D, Tantawy W, Lesniewski-Kmak K. Are you the author?
Division of Oncology and Hematology, Department of Internal Medicine, Cantonal Hospital Graubünden, Chur, Switzerland.
Reference: Urol Int. 2014;92(4):377-386.
doi: 10.1159/000358258
PubMed Abstract
PMID: 24802278
UroToday.com Bone Metastases Section
